학술논문
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial.
Document Type
Journal Article
Author
Source
Subject
*TRASTUZUMAB
*BREAST cancer
*BREAST
*HEART failure patients
*MEDICATION safety
*AGE groups
*
*
*
*
*
Language
ISSN
0344-5704
Abstract